Avalo Therapeutics Stock (NASDAQ: AVTX) stock price, news, charts, stock research, profile.
Open | $12.40 |
Close | - |
Volume / Avg. | 3.39K / 32.94K |
Day Range | 12.30 - 12.51 |
52 Wk Range | 3.95 - 79.20 |
Market Cap | $12.72M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 7.24% |
Days to Cover | 3.71 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Avalo Therapeutics (NASDAQ:AVTX) through any online brokerage.
Other companies in Avalo Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN) and Monopar Therapeutics (NASDAQ:MNPR).
There is no analysis for Avalo Therapeutics.
Avalo Therapeutics has a consensus price target of $12.92.
The stock price for Avalo Therapeutics (NASDAQ: AVTX) is $12.65 last updated July 16, 2024 at 8:34 AM EDT.
There are no upcoming dividends for Avalo Therapeutics.
Avalo Therapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Avalo Therapeutics.
Avalo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.